0
0
Industry
Geography
Report Type
Price
Publication date
Published Date
  • Product Insights

    $100 | November 2023
    Product Insights

    Rix’s Creek Coal Mine

    The Rix's Creek Coal Mine is a coal mine in Australia. It is currently in operation. Empower your strategies with our Rix's Creek Coal Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to...

  • Product Insights

    $100 | May 2023
    Product Insights

    Bloomfield – Rixs Creek Coal Mine Infrastructure Development – New South Wales

    Equip yourself with the essential tools needed to make informed and profitable decisions with our Bloomfield - Rixs Creek Coal Mine Infrastructure Development - New South Wales report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...

  • Company Profile

    $295 | February 2024
    Company Profile

    MeiraGTx Holdings Plc – Company Profile

    MeiraGTx Holdings Plc (MeiraGTx) is a gene therapy company that develops treatments for ocular, salivary gland and central nervous system diseases. The company’s product pipeline includes AAV-RPGR, AAV-RPE65, AAV-CNGB3, A006, AAV-GAD, AAV-UPF1 and AAV-AQP1. Its pipeline treats X-linked retinitis pigmentosa, gene deficiency, achromatopsia, macular degeneration, parkinson’s disease, amyotrophic lateral sclerosis, radiation-induced xerostomia and ophthalmology diseases. MeiraGTx is developing riboswitch inducible expression programs targeting ophthalmology and oncology indications, diabetes and metabolic disorders among others. The company operates in the UK, the...

    Add to Basket
  • Product Insights

    $500 | November 2022
    Product Insights

    Net Present Value Model: Idelvion

    Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Idelvion Drug Details Coagulation Factor IX...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.